---
schema_version: "secwatch.filing_event.v1"
accession: "0000320017-26-000012"
form_type: "8-K"
ticker: "LSTA"
cik: "0000320017"
company_name: "LISATA THERAPEUTICS, INC."
filed_at: "2026-02-27T23:59:59+00:00"
generated_at: "2026-05-15T23:17:01.056259+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lisata and Kuva extend exclusive negotiation deadline to March 7, 2026 for acquisition

## Summary
- Amendment to binding term sheet extends expiration from Feb 28 to March 7, 2026.
- Kuva Labs to acquire Lisata via tender offer and short-form merger under Section 251(h).
- No other changes to term sheet; parties continue negotiating purchase agreement.
- Acquisition remains subject to tender offer conditions and regulatory approvals.

## SEC filing metadata
- accession: 0000320017-26-000012
- form_type: 8-K
- ticker: LSTA
- cik: 0000320017
- company_name: LISATA THERAPEUTICS, INC.
- filed_at: 2026-02-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/320017/000032001726000012/0000320017-26-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/320017/000032001726000012/clbs-20260227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000320017-26-000012
- JSON: https://secwatch.observer/filing/0000320017-26-000012.json
- Plain text: https://secwatch.observer/filing/0000320017-26-000012.txt

## Source-grounded claims
- claim_id: 3c16bddcae6529c135ff49e36c318c12142df5fc
  claim: LISATA THERAPEUTICS, INC. amended Term Sheet Amendment with Kuva Labs Inc. (effective 2026-02-27).
  evidence_excerpt: On February 27, 2026, Lisata and Kuva entered into an amendment to the Term Sheet (the “Term Sheet Amendment”), whereby the parties agreed to extend the expiration date of the Term Sheet to March 7, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/320017/000032001726000012/0000320017-26-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.